Published on: February 1, 2022
£1.59m Talking Medicines fundraise at material valuation uplift
Tern’s portfolio company Talking Medicines, the digital health data
company, has announced a successful £1.59m fundraise at a significant
uplift to Tern’s book valuation. The announcement demonstrates the
success of the group’s investment strategy, delivering value from the
portfolio and reducing dependence on Tern for future funding. Tern’s
holding in Talking Medicines’ equity has increased from 23.4% to 23.8%,
with a book value of £1.79m, up 62% on the amount invested by Tern since
November 2020.
